Transce3nd’s CVS Health CVS Stock Holding History

Transce3nd’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-95	Closed	-$6.55K	–	359
2025 Q2	$6.55K	Buy	95 +13	+16%	+$852	﹤0.01%	677
2025 Q1	$5.55K	Sell	82 -140	-63%	-$8.38K	﹤0.01%	701
2024 Q4	$9.96K	Buy	+222	New	+$12.5K	﹤0.01%	755

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Transce3nd's CVS Position: Q3 2025 in Review

Transce3nd sold out of CVS Health (CVS) in Q3 2025, closing a stake of 95 shares — an estimated $6.55K sold.

Transce3nd first reported a position in CVS in Q4 2024 and held it in 3 quarters. The position peaked at $9.96K in Q4 2024. 1,837 funds tracked by Wall St. Rank hold CVS as of Q3 2025.

Transce3nd reported no remaining CVS Health position as of Q3 2025 after selling out during the quarter.
Transce3nd sold 95 CVS Health shares in Q3 2025, an estimated $6.55K.
Transce3nd first reported a position in CVS Health in Q4 2024 and held it in 3 quarters.
Transce3nd's CVS Health position peaked at $9.96K in Q4 2024.
1,837 funds tracked by Wall St. Rank held CVS Health as of Q3 2025.

Based on Transce3nd's 13F filing for Q3 2025, filed 12 Nov 2025.